Charcoal-filtered versus regular cigarette filters: effects on perceptions, smoking, and exposure
Official title: A Randomized Trial of Charcoal-filtered Cigarettes on Product Perceptions, Smoking Behaviors, and Toxicant Exposure
Run by Rutgers, The State University of New Jersey · NCT07348679 · Data updated 2026-11-12
This trial will test whether using charcoal-filtered versus regular cigarette filters changes what adult smokers think of the product, how they smoke, and their exposure to harmful chemicals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 252 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | April 27, 2026 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT07348679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21 or older who smoke at least 5 cigarettes per day, primarily use non-menthol brands other than Natural American Spirit, are not trying to quit, and can attend weekly lab visits in English are ideal candidates.
✕Probably not a fit
People who primarily use menthol or Natural American Spirit cigarettes, are enrolled in or planning to join a quit program, are under 21, or cannot attend in-person weekly visits are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 5-week, open-label, parallel-design randomized trial in adult daily smokers. After a baseline period smoking their usual brand, participants are randomized to smoke cigarettes with charcoal filters (with or without marketing) or non-charcoal filters for four weeks. Participants come weekly to a laboratory session to smoke two cigarettes under observation, provide urine and carbon monoxide samples, and complete questionnaires on perceptions and behavior. Primary outcomes include product perceptions, smoking behavior measures, and biomarkers of exposure to tobacco-related toxicants.
Why it matters
Potential benefit: If successful, the results could show whether charcoal filters reduce exposure to toxicants or change smoking behavior, informing product design and regulation that might lower harm for smokers.
How similar studies have gone: Prior small laboratory studies of charcoal or novel filters have shown mixed and limited evidence for reducing exposure or changing behavior, so this approach is not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible subjects will be: 1. Male and female smokers who are at least 21 years of age and self-report smoking at least 5 cigarettes per day for at least the past 6 months. 2. Smokers of primarily non-menthol cigarettes of brands other than Natural American Spirit. 3. Not currently undergoing smoking cessation treatment or trying to quit. 4. Able to communicate fluently in English (speaking, writing, and reading). 5. Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the combined consent and HIPAA form. Exclusion Criteria: * Subjects who self-report and/or present with the following criteria will not be eligible to participate in the study: Smoking Behavior 1. Use of menthol or Natural American Spirit cigarettes as preferred/regular brand (defined as using \>20% of the time). 2. Enrollment or plans to enroll in a smoking cessation program in the next month. 3. Provide an initial Carbon Monoxide (CO) reading \< 5 parts per million (ppm). Alcohol/Drugs 1. History of substance abuse (other than nicotine) in the past 12 months and/or currently receiving medical treatment for substance abuse. 2. Current alcohol consumption that exceeds 25 standard drinks/week. Medical 1. Women who are pregnant, planning a pregnancy, and/or lactating. 2. Any impairment including, but not limited to, visual, physical, and/or neurological impairments preventing the completion of procedures included within this protocol. Notable impairments will be evaluated by the PI and eligibility will be determined on a case-by-case basis. 3. Color blindness. 4. Serious or unstable disease within the past 12 months (e.g. heart disease, cancer). Applicable conditions will be evaluated by the Principal Investigator and eligibility will be determined on a case-by-case basis. Psychiatric As determined by self-report: 1. Lifetime history or current diagnosis of psychosis, bipolar disorder, and/or schizophrenia. 2. Current diagnosis of major depression. Subjects with a history of major depression, in remission for 6 months or longer, are considered eligible. Other Additionally, participants may be deemed ineligible for any of the following general reasons at any point throughout the study, as well as during the initial telephone screen, at the discretion of the PI: * Significant non-compliance with protocol and/or study design. * Past, current, anticipated, or pending enrollment in another research program over the study period that could potentially impact study data. * Any medical condition, illness, disorder, adverse event (AE), or concomitant medication that could compromise participant safety or significantly impact study performance.
Where it's running
-
Institute for Nicotine and Tobacco Studies
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Melissa Mercincavage, PhD — Rutgers, The State University of New Jersey
- Study coordinator: Matthew Joy, MPH
- Email: maj206@ints.rutgers.edu
- Phone: 848-267-8284
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Empowering patients to get lung cancer screening with support and navigation
This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.
-
Promoting breastfeeding to prevent postpartum smoking relapse
This study tests whether a breastfeeding promotion program can help ex-smokers stay smoke-free after giving birth.
-
Communal coping in couples where both partners smoke during a quit attempt
This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.
-
Non-surgical gum treatment effects on saliva markers in smokers and non-smokers with periodontitis
This test will see if deep cleaning (scaling and root planing) changes saliva markers linked to bone loss in adults with Stage II–III periodontitis, comparing current smokers and non-smokers.
-
Using lung cancer screening CT scans to find COPD (MAP2)
This project will use lung cancer screening CT scans and spirometry in current and former smokers aged 50–80 with at least 20 pack-years to see if CT findings can identify people who have COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.